Latest filing published 18 Nov 2024 for Dyne Therapeutics, Inc., €450k.
Filing timeline
BuySaleInsider track record
Carlo Incerti: trading record in brief
Carlo Incerti discloses dealings in Dyne Therapeutics, Inc. to SEC (Form 4). The record holds 2 filings, all for trades on 18 November 2024.
No open-market purchase appears, only 1 sale worth €450k. Besides market trades, the filings include 1 option exercise.
On 18 November 2024 came the latest disclosure, an open-market sale for €450k in Dyne Therapeutics, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Carlo Incerti
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,500 shares@ US$28.7376.8% of flowCommon StockSEC:0000950170-24-128176:1
- 16,500 shares@ US$8.69100.0% of flowCommon StockSEC:0000950170-24-128176:0
2 of 2 declarations
